| High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML E Tiacci, A Venanzi, S Ascani, A Marra, V Cardinali, G Martino, V Codoni, ... New England Journal of Medicine 379 (10), 981-984, 2018 | 60 | 2018 |
| Current status and future perspectives in targeted therapy of NPM1-mutated AML R Ranieri, G Pianigiani, S Sciabolacci, VM Perriello, A Marra, V Cardinali, ... Leukemia 36 (10), 2351-2367, 2022 | 35 | 2022 |
| Decreased NOTCH1 activation correlates with response to ibrutinib in chronic lymphocytic leukemia B Del Papa, S Baldoni, E Dorillo, F De Falco, C Rompietti, D Cecchini, ... Clinical Cancer Research 25 (24), 7540-7553, 2019 | 25 | 2019 |
| Dissecting clonal hematopoiesis in tissues of patients with classic Hodgkin lymphoma A Venanzi, A Marra, G Schiavoni, SG Milner, R Limongello, A Santi, ... Blood cancer discovery 2 (3), 216-225, 2021 | 23 | 2021 |
| CD123 Is Consistently Expressed on NPM1-Mutated AML Cells VM Perriello, I Gionfriddo, R Rossi, F Milano, F Mezzasoma, A Marra, ... Cancers 13 (3), 496, 2021 | 21 | 2021 |
| NK cells in chronic lymphocytic leukemia and their therapeutic implications P Sportoletti, F De Falco, B Del Papa, S Baldoni, V Guarente, A Marra, ... International Journal of Molecular Sciences 22 (13), 6665, 2021 | 19 | 2021 |
| Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness C Pirillo, F Birch, FS Tissot, SG Anton, M Haltalli, V Tini, I Kong, C Piot, ... Blood advances 6 (10), 3126-3141, 2022 | 14 | 2022 |
| Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice P Sportoletti, D Sorcini, AG Guzman, JM Reyes, A Stella, A Marra, ... Leukemia 35 (7), 1949-1963, 2021 | 13 | 2021 |
| Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML G Pianigiani, A Gagliardi, F Mezzasoma, F Rocchio, V Tini, B Bigerna, ... Blood Advances 6 (22), 5938-5949, 2022 | 12 | 2022 |
| Novel immune cell-based therapies to eradicate high-risk acute myeloid leukemia R Limongello, A Marra, A Mancusi, S Bonato, E Hoxha, L Ruggeri, S Hui, ... Frontiers in Immunology 12, 695051, 2021 | 12 | 2021 |
| IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML VM Perriello, MC Rotiroti, I Pisani, S Galimberti, G Alberti, G Pianigiani, ... Blood Advances 7 (12), 2855-2871, 2023 | 7 | 2023 |
| HHV8-positive Castleman disease and in situ mantle cell neoplasia within dermatopathic lymphadenitis, in longstanding psoriasis M Zanelli, L Stingeni, M Zizzo, G Martino, F Sanguedolce, A Marra, ... Diagnostics 11 (7), 1150, 2021 | 6 | 2021 |
| Placental myeloid sarcoma A Marra, G Martino Blood, The Journal of the American Society of Hematology 135 (16), 1410-1410, 2020 | 4 | 2020 |
| Collision diffuse large B cell lymphoma and myeloid sarcoma in the liver A Marra, G Martino, N Scarpelli, V Perriello, R Limongello, S Ascani Annals of Hematology 100, 2649-2651, 2021 | 2 | 2021 |
| NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models S Baldoni, L Ruggeri, B Del Papa, D Sorcini, F Guardalupi, F Ulbar, ... Bone Marrow Transplantation 56 (8), 2019-2023, 2021 | 2 | 2021 |
| Richter's transformation in the heart A Marra, F Adamo, S Baldoni, ME Laurenti, M Giansanti, S Pasquino, ... The Lancet Oncology 22 (7), e341, 2021 | 2 | 2021 |
| Uterine myeloid sarcoma G Martino, M Zanelli, M Zizzo, M Quintini, L Ricci, A Marra, S Ascani Annals of Hematology 99, 1671-1672, 2020 | 2 | 2020 |
| Flower cells of tropical descent: a challenging case of adult T-cell leukemia/lymphoma G Martino, M Zanelli, A Marra, M Quintini, M Zizzo, S Ascani, MP Martelli, ... Tumori Journal 105 (6), NP38-NP42, 2019 | 2 | 2019 |
| CD47 expression in acute myeloid leukemia varies according to genotype A Marra, AU Akarca, G Martino, A Ramsay, S Ascani, VM Perriello, ... Haematologica 108 (12), 3491, 2023 | 1 | 2023 |
| Tuned IL3-Zetakine coupled to a CD33 costimulatory receptor as a dual CAR for safer and selective targeting of acute myeloid leukemia VM Perriello, MC Rotiroti, I Pisani, S Galimberti, G Alberti, G Pianigiani, ... Blood 140 (Supplement 1), 10237-10238, 2022 | 1 | 2022 |
